The medication has a half-life of approximately seven days, which allows for once-weekly dosing and contributes to stable blood levels throughout the week
Screening should also assess weight suppression (the difference between a patients maximum and current weight) and consider whether, following weight loss, patients experienced an intense fear of weight gain or symptoms of starvation (e.g., low body temperature, reduced heart rate, preoccupation with thoughts of food, irritability, decreased sexual desire, or social isolation)
But you might still qualify if you have the right documented health condition
The three recommended injection sites are: Abdomen (stomach area) : Most people find this the easiest area to reach
dark yellow or amber suggests dehydration
For more information, visit www.hims.com/weight-loss or www.forhers.com/weight-loss Assets Download Contact Susan Cadrecha [email protected] 1 Ozempic is not FDA-approved for weight loss